|
|
Blood, 1 February 2005, Vol. 105, No. 3, pp. 1179-1186.
Prepublished online as a Blood First Edition Paper on October 7, 2004; DOI 10.1182/blood-2004-07-2833.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Differential regulation of virus-specific T-cell effector functions following activation by peptide or innate cytokines
Carol Beadling, and
Mark K. Slifka
From the Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR.
Robust CD8+ T-cell activation is vital for the recovery from many viral infections and is orchestrated via the integration of signals delivered through surface molecules, including the T-cell antigen receptors (TcRs) and cytokine receptors. Little is known about how virus-specific T cells interpret sequential or combined stimulation through these receptors, which must undoubtedly occur in vivo during antiviral immune responses. When measured in real time, peptide antigen and the cytokines, interleukin 12 (IL-12) and IL-18, independently regulate the on/off kinetics of protective (interferon  , tumor necrosis factor  ) and immunomodulatory (IL-2, CD40L) cytokine production by activated T cells and memory T cells. The remarkable differences in effector functions elicited by innate or adaptive signals (IL-12/ IL-18 or peptide, respectively) illustrate the complex and stringent regulation of cytokine expression by CD8+ T cells. Together, these results indicate how antiviral T cells incorporate multiple signals from their local microenvironment and tailor their cytokine responses accordingly.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Koguchi, T. J. Thauland, M. K. Slifka, and D. C. Parker
Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner
Blood,
October 1, 2007;
110(7):
2520 - 2527.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Srinivasan, R.-M. Salazar-Gonzalez, M. Jarcho, M. M. Sandau, L. Lefrancois, and S. J. McSorley
Innate Immune Activation of CD4 T Cells in Salmonella-Infected Mice Is Dependent on IL-18
J. Immunol.,
May 15, 2007;
178(10):
6342 - 6349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-P. Raue and M. K. Slifka
Pivotal Advance: CTLA-4+ T cells exhibit normal antiviral functions during acute viral infection
J. Leukoc. Biol.,
May 1, 2007;
81(5):
1165 - 1175.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Tellides and J. S. Pober
Interferon-{gamma} Axis in Graft Arteriosclerosis
Circ. Res.,
March 16, 2007;
100(5):
622 - 632.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ranjbaran, S. I. Sokol, A. Gallo, R. E. Eid, A. O. Iakimov, A. D'Alessio, J. R. Kapoor, S. Akhtar, C. J. Howes, M. Aslan, et al.
An Inflammatory Pathway of IFN-{gamma} Production in Coronary Atherosclerosis
J. Immunol.,
January 1, 2007;
178(1):
592 - 604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Maxwell, R. Yadav, R. J. Rossi, C. E. Ruby, A. D. Weinberg, H. L. Aguila, and A. T. Vella
IL-18 Bridges Innate and Adaptive Immunity through IFN-{gamma} and the CD134 Pathway
J. Immunol.,
July 1, 2006;
177(1):
234 - 245.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Kan-Mitchell, M. Bajcz, K. L. Schaubert, D. A. Price, J. M. Brenchley, T. E. Asher, D. C. Douek, H. L. Ng, O. O. Yang, C. R. Rinaldo Jr., et al.
Degeneracy and Repertoire of the Human HIV-1 Gag p1777-85 CTL Response.
J. Immunol.,
June 1, 2006;
176(11):
6690 - 6701.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
